265 related articles for article (PubMed ID: 28319090)
1. A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
de la Rosa J; Weber J; Friedrich MJ; Li Y; Rad L; Ponstingl H; Liang Q; de Quirós SB; Noorani I; Metzakopian E; Strong A; Li MA; Astudillo A; Fernández-García MT; Fernández-García MS; Hoffman GJ; Fuente R; Vassiliou GS; Rad R; López-Otín C; Bradley A; Cadiñanos J
Nat Genet; 2017 May; 49(5):730-741. PubMed ID: 28319090
[TBL] [Abstract][Full Text] [Related]
2. Disentangling
de la Rosa J; Weber J; Rad R; Bradley A; Cadiñanos J
Mol Cell Oncol; 2017; 4(4):e1325550. PubMed ID: 28868343
[TBL] [Abstract][Full Text] [Related]
3. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression.
Rangel R; Lee SC; Hon-Kim Ban K; Guzman-Rojas L; Mann MB; Newberg JY; Kodama T; McNoe LA; Selvanesan L; Ward JM; Rust AG; Chin KY; Black MA; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7749-E7758. PubMed ID: 27849608
[TBL] [Abstract][Full Text] [Related]
4. Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor Suppressor.
Dorr C; Janik C; Weg M; Been RA; Bader J; Kang R; Ng B; Foran L; Landman SR; O'Sullivan MG; Steinbach M; Sarver AL; Silverstein KA; Largaespada DA; Starr TK
Mol Cancer Res; 2015 Aug; 13(8):1238-47. PubMed ID: 25995385
[TBL] [Abstract][Full Text] [Related]
5. Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma.
Kodama M; Shimura H; Tien JC; Newberg JY; Kodama T; Wei Z; Rangel R; Yoshihara K; Kuruma A; Nakae A; Hashimoto K; Sawada K; Kimura T; Jenkins NA; Copeland NG
Cancer Res; 2021 Nov; 81(21):5413-5424. PubMed ID: 34475109
[TBL] [Abstract][Full Text] [Related]
6. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
[TBL] [Abstract][Full Text] [Related]
7. Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.
Chen L; Jenjaroenpun P; Pillai AM; Ivshina AV; Ow GS; Efthimios M; Zhiqun T; Tan TZ; Lee SC; Rogers K; Ward JM; Mori S; Adams DJ; Jenkins NA; Copeland NG; Ban KH; Kuznetsov VA; Thiery JP
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2215-E2224. PubMed ID: 28251929
[TBL] [Abstract][Full Text] [Related]
8. Sleeping Beauty insertional mutagenesis screen identifies the pro-metastatic roles of CNPY2 and ACTN2 in hepatocellular carcinoma tumor progression.
Lo LH; Lam CY; To JC; Chiu CH; Keng VW
Biochem Biophys Res Commun; 2021 Feb; 541():70-77. PubMed ID: 33482578
[TBL] [Abstract][Full Text] [Related]
9. A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis.
Starr TK; Scott PM; Marsh BM; Zhao L; Than BL; O'Sullivan MG; Sarver AL; Dupuy AJ; Largaespada DA; Cormier RT
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5765-70. PubMed ID: 21436051
[TBL] [Abstract][Full Text] [Related]
10. Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development.
Takeda H; Rust AG; Ward JM; Yew CC; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2057-65. PubMed ID: 27006499
[TBL] [Abstract][Full Text] [Related]
11. An in vitro system to characterize prostate cancer progression identified signaling required for self-renewal.
Salah M; Nishimoto Y; Kohno S; Kondoh A; Kitajima S; Muranaka H; Nishiuchi T; Ibrahim A; Yoshida A; Takahashi C
Mol Carcinog; 2016 Dec; 55(12):1974-1989. PubMed ID: 26621780
[TBL] [Abstract][Full Text] [Related]
12. A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.
Moriarity BS; Otto GM; Rahrmann EP; Rathe SK; Wolf NK; Weg MT; Manlove LA; LaRue RS; Temiz NA; Molyneux SD; Choi K; Holly KJ; Sarver AL; Scott MC; Forster CL; Modiano JF; Khanna C; Hewitt SM; Khokha R; Yang Y; Gorlick R; Dyer MA; Largaespada DA
Nat Genet; 2015 Jun; 47(6):615-24. PubMed ID: 25961939
[TBL] [Abstract][Full Text] [Related]
13. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
[TBL] [Abstract][Full Text] [Related]
14. Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma.
Mann KM; Ward JM; Yew CC; Kovochich A; Dawson DW; Black MA; Brett BT; Sheetz TE; Dupuy AJ; ; Chang DK; Biankin AV; Waddell N; Kassahn KS; Grimmond SM; Rust AG; Adams DJ; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):5934-41. PubMed ID: 22421440
[TBL] [Abstract][Full Text] [Related]
15. Insertional mutagenesis by a hybrid piggyBac and sleeping beauty transposon in the rat.
Furushima K; Jang CW; Chen DW; Xiao N; Overbeek PA; Behringer RR
Genetics; 2012 Dec; 192(4):1235-48. PubMed ID: 23023007
[TBL] [Abstract][Full Text] [Related]
16. PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice.
Rad R; Rad L; Wang W; Cadinanos J; Vassiliou G; Rice S; Campos LS; Yusa K; Banerjee R; Li MA; de la Rosa J; Strong A; Lu D; Ellis P; Conte N; Yang FT; Liu P; Bradley A
Science; 2010 Nov; 330(6007):1104-7. PubMed ID: 20947725
[TBL] [Abstract][Full Text] [Related]
17. Rapid in vivo validation of candidate drivers derived from the PTEN-mutant prostate metastasis genome.
Cho H; Herzka T; Stahlhut C; Watrud K; Robinson BD; Trotman LC
Methods; 2015 May; 77-78():197-204. PubMed ID: 25592467
[TBL] [Abstract][Full Text] [Related]
18. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
[TBL] [Abstract][Full Text] [Related]
19. Discovery and functional characterization of a neomorphic PTEN mutation.
Costa HA; Leitner MG; Sos ML; Mavrantoni A; Rychkova A; Johnson JR; Newton BW; Yee MC; De La Vega FM; Ford JM; Krogan NJ; Shokat KM; Oliver D; Halaszovich CR; Bustamante CD
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13976-81. PubMed ID: 26504226
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer.
Alioui A; Dufour J; Leoni V; Loregger A; Moeton M; Iuliano L; Zerbinati C; Septier A; Val P; Fouache A; Russo V; Volle DH; Lobaccaro JA; Zelcer N; Baron S
Nat Commun; 2017 Sep; 8(1):445. PubMed ID: 28874658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]